NATIONAL RESEARCH CORP
10-Q/A, 1999-02-26
TESTING LABORATORIES
Previous: NATIONAL MUNICIPAL TRUST & SUBSEQUENT TRUSTS, NSAR-U, 1999-02-26
Next: NATIONAL RESEARCH CORP, 10-Q/A, 1999-02-26





                                  UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                   FORM 10-Q/A

                               AMENDMENT NO. 1 TO

[X]      QUARTERLY  REPORT  PURSUANT  TO SECTION 13 OR 15(d)
         OF THE SECURITIES EXCHANGE ACT OF 1934

         For the quarterly period ended June 30, 1998

                             or

[ ]      TRANSITION  REPORT  PURSUANT TO SECTION 13 OR 15(d)
         OF THE SECURITIES EXCHANGE ACT OF 1934

         For  the   transition   period  from   ________  to __________

                         Commission File Number 0-29466

                          National Research Corporation
             (Exact name of Registrant as specified in its charter)

                      Wisconsin                  47-063400     
          (State or other jurisdiction of    (I.R.S. Employer
           incorporation or organization)    Identification No.)

                     1033 "O" Street, Lincoln Nebraska 68508
               (Address of principal executive offices) (Zip Code)

                                 (402) 475-2525
              (Registrant's telephone number, including area code)

Indicate by check mark whether the Registrant (1) has filed all reports required
to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during
the  preceding 12 months (or for such  shorter  period that the  registrant  was
required  to file  such  reports),  and  (2) has  been  subject  to such  filing
requirements for the past 90 days. Yes X No

Indicate the number of shares  outstanding  of each of the  issuer's  classes of
common stock, as of the latest practicable date.

Common  Stock,  $.001 par value,  outstanding  as of August 10, 1998:  7,305,000
shares



<PAGE>


          The undersigned  registrant  hereby amends Items 1 and 2 of Part I and
Item 6 of Part II of its  Quarterly  Report on Form 10-Q for the  quarter  ended
June 30, 1998 to provide in their  entirety as set forth  below.  The  financial
information  for the three and six months ended June 30, 1998 has been  restated
to reflect a revised  charge for acquired in process  research  and  development
cost and a correction in the accrual of interest income. The charge for acquired
research and  development  cost was revised to conform with recent guidance from
the Securities and Exchange Commission on such valuations.



                                      -2-

<PAGE>



                         PART I - Financial Information

ITEM 1   Financial Statements

                          NATIONAL RESEARCH CORPORATION
                            CONDENSED BALANCE SHEETS

                                                      June 30,    December 31,
                                                        1998         1997
                                                    -----------   ------------
                                                    (unaudited)
                   Assets
Current assets:
   Cash and cash equivalents                       $  1,424,101   $  4,688,352
   Investments in marketable debt                   
     securities                                      12,041,555     13,220,553
   Trade accounts receivable 
     less allowance for doubtful                      
     accounts of $72,808 in 1998
     and $62,808 in 1997                              3,917,463      3,094,772
   Unbilled revenues                                    913,729        559,856
   Prepaid expenses and other                           831,787        184,156
   Other receivables                                    648,874          -    
   Deferred income taxes                                144,476        127,225
                                                    -----------   ------------

             Total current assets                    19,921,985     21,874,914
                                                    -----------   ------------

Property and equipment, net of accumulated
   depreciation and amortization                      1,271,930        519,955
Deferred income taxes                                 1,165,856        155,775
Other                                                    87,175         12,482
Goodwill and other intangibles, net of 
  accumulated amortization                            3,004,247          -    
                                                    -----------   ------------

             Total assets                          $ 25,451,193   $ 22,563,126
                                                    ===========   ============

         Liabilities and Shareholders' Equity
Current liabilities:
   Current portion - notes payable                 $     30,754   $         - 
   Accounts payable and accrued expenses              1,761,747        615,930
   Accrued wages, bonuses and profit sharing          1,544,866      1,161,917
   Income taxes payable                                  48,786        118,000
   Billings in excess of revenues earned              3,937,792      2,297,751
                                                    -----------   ------------

             Total current liabilities                7,323,945      4,193,598

Notes payable, net of current portion                    89,549             - 
Bonuses and profit sharing accruals                     318,117        248,684
Other accrued expense                                   321,529          -    
                                                    -----------   ------------

             Total long-term liabilities                729,195        248,684
                                                    ------------  ------------

             Total liabilities                        8,053,140      4,442,282
                                                    -----------   ------------

Shareholders' equity:
   Common stock, $.001 par value; authorized
     20,000,000 shares, issued and                       
     outstanding 7,305,000                                7,305          7,305
   Preferred stock, $.01 par value;
     authorized 2,000,000
     shares, no shares issued and                            
     outstanding                                             -              -
   Additional paid-in capital                        16,839,839     16,839,839
   Retained earnings                                    550,909      1,273,700
                                                    ------------  ------------

             Total shareholders' equity              17,398,053     18,120,844
                                                    -----------   ------------

             Total liabilities and 
               shareholders' equity                $ 25,451,193   $ 22,563,126
                                                    ===========   ============

See accompanying notes to condensed financial statements.



                                      -3-


<PAGE>

<TABLE>
                          NATIONAL RESEARCH CORPORATION

                         CONDENSED STATEMENTS OF INCOME
                                   (Unaudited)
<CAPTION>

                                                         Three months ended         Six months ended
                                                              June 30,                  June 30,
                                                    ------------------------    -----------------------
                                                      1998           1997          1998          1997
                                                    ----------    ----------    ---------     ---------
Revenues:
<S>                                                <C>            <C>          <C>           <C>       
    Renewable performance tracking services
      and custom research                          $ 3,859,714    $3,407,093   $6,964,710    $6,506,266
    Renewable syndicated service                       170,003       103,691      471,107       444,312
                                                    ----------     --------     ---------     ---------

                Total revenues                       4,029,717     3,510,784    7,435,817     6,950,578
                                                    ----------     ---------    ----------    ---------

Operating expenses:
    Direct expenses                                  2,015,961     1,617,304    3,524,922     3,010,725
    Selling, general and administrative              1,242,811       886,619    2,431,399     1,837,420
    Depreciation and amortization                       66,363        37,971      118,356        79,568
    Acquired in-process research and
      development cost                               2,737,542          --      2,737,542          --  
    Severance charge                                   303,740          --        303,740          --  
                                                    ----------     ---------    ----------    ---------

                Total operating expenses             6,366,417     2,541,894    9,115,959     4,927,713
                                                    ----------     ---------    ---------     ---------

                Operating income (loss)             (2,336,700)      968,890   (1,680,142)    2,022,865

Other income:
    Interest income                                    255,330        51,963      517,530        97,030
    Interest expense                                    (1,303)         --         (1,303)         --  
                                                    ----------     ---------    ----------    ---------

                Total other income                     254,027        51,963      516,227        97,030
                                                    ----------     ---------    ---------     ---------

                Income (loss) before income taxes   (2,082,673)    1,020,853   (1,163,915)    2,119,895

Income tax benefit                                    (798,125)         --       (441,125)         -- 
                                                    ----------     ---------    ---------     ---------

                Net income (loss)                   (1,284,548)    1,020,853     (722,790)    2,119,895

Pro forma income taxes                                    --         408,341         --         847,958
                                                    ----------     ---------    ---------     ---------

Pro forma net income (loss)                        $(1,284,548)   $  612,512   $ (722,790)   $1,271,937
                                                    ==========     =========    ==========    =========

Pro forma net income per share--basic
    and diluted                                    $     (0.18)   $     0.10   $    (0.10)   $     0.21
                                                    ==========     =========    =========     =========

Weighted average shares and share equivalents
   outstanding--basic and diluted                    7,305,000     6,184,812    7,305,000     6,184,812
                                                    ==========     =========    =========     =========
</TABLE>

See accompanying notes to condensed financial statements.


                                      -4-

<PAGE>


                          NATIONAL RESEARCH CORPORATION

                       CONDENSED STATEMENTS OF CASH FLOWS
                                   (Unaudited)
                                                           Six months ended
                                                               June 30,
                                                      -------------------------
                                                         1998          1997
                                                      ------------  -----------

Cash flows from operating activities:
    Net income (loss)                                 $  (722,790)  $ 2,119,895
    Adjustments to reconcile net income to net cash
      provided by operating activities:
        Depreciation and amortization                     118,356        79,568
        Acquired in-process research and development
          cost, net of tax                              1,669,309            - 
        Changes in assets and liabilities:
           Trade accounts receivable                      301,027      (954,206)
           Unbilled revenues                             (144,197)     (371,576)
           Prepaid expenses and other                    (699,678)     (582,407)
           Deferred income taxes                           40,901      (300,514)
           Accounts payable and accrued expenses          947,658       394,456
           Accrued wages, bonuses and profit sharing      303,612            - 
           Income taxes payable                           (69,214)           - 
           Billings in excess of revenues earned          794,460     1,126,830
                                                      ------------  -----------

                  Net cash provided by operating 
                    activities                          2,539,444     1,512,046
                                                      ------------  -----------

Cash flows from investing activities:
    Purchases of property and equipment                  (713,731)     (232,452)
    Acquisition, net of cash acquired                  (5,616,353)           - 
    Accounts receivable - other                          (648,874)           - 
    Purchases of securities available-for-sale         (8,169,883)     (329,871)
    Proceeds from the maturities of securities 
      available-for-sale                                9,348,881     1,500,057
                                                      ------------  -----------

                  Net cash provided by (used in)
                    investing activities               (5,799,960)      937,734
                                                      ------------  -----------

Cash flows from financing activities:
    Dividends paid                                           -       (1,610,330)
    Payments on notes payable                              (3,735)           - 
                                                      -----------   -----------

                  Net cash provided by (used 
                    in) financing activities               (3,735)   (1,610,330)
                                                      -----------   -----------

                  Net increase (decrease) in cash 
                    and cash equivalents               (3,264,251)      839,450

Cash and cash equivalents at beginning of period        4,688,352     2,782,212
                                                      -----------   -----------

Cash and cash equivalents at end of period            $ 1,424,101   $ 3,621,662
                                                      ===========   ===========

Supplemental disclosure of cash paid for:

    Interest                                          $     1,303   $        - 
                                                      ===========   ===========

    Taxes                                             $   577,650   $        - 
                                                      ===========   ===========

See accompanying notes to condensed financial statements.


                                      -5-

<PAGE>


                          NATIONAL RESEARCH CORPORATION

                     Notes to Condensed Financial Statements


1.       INTERIM FINANCIAL REPORTING

The condensed balance sheet of National Research  Corporation (the "Company") at
December 31, 1997 was derived from the  Company's  audited  balance  sheet as of
that date. All other financial statements contained herein are unaudited and, in
the opinion of management,  include all adjustments  (consisting  only of normal
recurring  adjustments) the Company considers  necessary for a fair presentation
of financial  position,  results of operations and cash flows in accordance with
generally accepted accounting principles.

Certain  information  and footnote  disclosures  normally  included in financial
statements prepared in accordance with generally accepted accounting  principles
have been condensed or omitted.  These condensed financial  statements should be
read in  conjunction  with the financial  statements  and notes thereto that are
included in the Company's Form 10-K for the fiscal year ended December 31, 1997,
filed with the Securities and Exchange Commission in March 1998.

On January 1, 1998,  the Company  adopted the  American  Institute  of Certified
Public Accountants Statement of Position No. 98-1 (SOP 98-1), Accounting for the
Costs of Computer  Software  Developed or Obtained for Internal Use.  Under that
accounting  standard,  the Company expenses as incurred  computer software costs
incurred  in the  preliminary  project  stage,  which  involved  the  conceptual
formulation, evaluation and selection of technology alternatives. Costs incurred
related to the design,  coding  installation  and testing of software during the
application  project  stage are  capitalized.  Costs  incurred  for training and
application  maintenance  are expenses as incurred.  The Company has capitalized
approximately  $486,000 of costs  incurred for the  development  of internal use
software for the six months ended June 30, 1998,  with such costs  classified as
property  and  equipment.  Prior to January 1, 1998,  the  Company's  accounting
policy was to expense as incurred all costs of software  developed  for internal
use. Costs  incurred  prior to January 1, 1998, for the  development of internal
use software have not been adjusted or  capitalized as a result of the Company's
adoption of SOP 98-1.

2.       S CORPORATION STATUS

From August 1, 1994, through October 13, 1997 (three days prior to the Company's
initial public offering), the Company was an S Corporation and, accordingly, was
not subject to Federal and state  income taxes for the six months ended June 30,
1997.  Pro forma net  income  reflects a pro forma tax  provision  at a combined
Federal and state rate of 40% for the  periods the Company was an S  Corporation
as if it had been a C Corporation.  Since October 14, 1997, the Company has been
C Corporation.

                                      -6-

<PAGE>


ITEM 2

                     MANAGEMENT'S DISCUSSION AND ANALYSIS OF
                  FINANCIAL CONDITION AND RESULTS OF OPERATIONS

Results of Operations

The following table sets forth, for the periods  indicated,  selected  financial
information derived from the Company's condensed financial statements, expressed
as a percentage of total revenues. The trends illustrated in the following table
may not necessarily be indicative of future results. The discussion that follows
the table should be read in conjunction with the condensed financial statements.
<TABLE>
<CAPTION>
                                                            Percentage of Total Revenues
                                                         ---------------------------------
                                                           Three months       Six months 
                                                          ended June 30,    ended June 30,
                                                         -----------------   -------------
                                                           1998      1997     1998    1997
                                                         -----------------   -------------
Revenues:
<S>                                                       <C>       <C>      <C>     <C>  
    Renewable performance tracking services
        and custom research                                95.8%     97.0%    93.7%   93.6%
    Renewable syndicated service                            4.2       3.0      6.3     6.4
                                                          ---------------    -------------
                        Total revenues                    100.0     100.0    100.0   100.0
                                                          ---------------    -------------

Operating expenses:
    Direct expenses                                        50.0      46.1     47.4    43.3
    Selling, general and administrative                    30.9      25.3     32.7    26.4
    Depreciation and amortization                           1.6       1.0      1.5     1.1
    Acquired in-process research and development cost      67.9        --     36.8      --
    Severance charge                                        7.5        --      4.1      --
                                                          ---------------    -------------
                  Total operating expenses:               157.9      72.4    122.5    70.8
                                                          ---------------    -------------

Operating income (loss)                                   (57.9%)    27.6%   (22.5%)  29.2%
                                                          ===============    =============
</TABLE>

Three Months Ended June 30, 1998 Compared to Three Months Ended June 30, 1997

Total revenues.  Total revenues  increased 14.8% in the three-month period ended
June 30, 1998, to $4.0 million from $3.5 million in the three month period ended
June 30,  1997.  Revenues  from the  Company's  renewable  performance  tracking
services and custom research  increased 13.3% to $3.9 million in the three month
period  ended June 30,  1998 from $3.4  million in the same  period  during 1997
primarily  due to the addition of new clients,  the  acquisition  of  Healthcare
Research Systems, Ltd. ("HRS") in June 1998 and, to a lesser extent, an increase
in the scope of existing tracking projects. Revenues for the Company's renewable
syndicated  service  increased 64.0% to $170,000 in the three month period ended
June 30, 1998 compared to $104,000 in the same three month period in 1997.  Such
an  increase  reflects  increased  sales of the 1997  annual  edition of the NRC
Healthcare Market Guide following its release in the prior year.

Direct  expenses.  Direct  expenses  increased  24.7%  to  $2.0  million  in the
three-month  period  ended June 30,  1998 from $1.6  million in the same  period
during  1997.  The  increase  in direct  expenses  in the 1998 period was due to
increases in postage and printing expenses of $36,000, outside field services of
$57,000 and labor and payroll expenses of $355,000,  which were due partially to



                                      -7-

<PAGE>

increased  costs  associated with the addition of a telephone call center and to
increased revenues.  Direct expenses increased as a percentage of total revenues
to 50.0% in the  three-month  period ended June 30, 1998,  from 46.1% during the
same period of 1997.

Selling, general and administrative expenses. Selling general and administrative
expenses  increased 40.2% to $1.2 million for the three-month  period ended June
30, 1998 from $887,000 for the same period in 1997.  This increase was primarily
due to an increase of $288,000  associated  with the  expansion of the Company's
sales  and  marketing  workforce  and  $64,000  associated  with  being a public
company. Sales, general and administrative expenses increased as a percentage of
total  revenues to 30.8% for the  three-month  period ended June 30, 1998,  from
25.3% for the same period in 1997.

Depreciation and amortization.  Depreciation and amortization expenses increased
74.8% to $66,000 in the  three-month  period ended June 30, 1998 from $38,000 in
the same period of 1997 partially due to the  acquisition  of HRS.  Depreciation
and amortization expenses as a percentage of total revenues increased to 1.6% in
the  three-month  period  ended June 30,  1998,  from 1.1% in the same period of
1997.

Acquired  in-process  research and  development  cost and severance  charge.  In
connection  with the  acquisition  of HRS in June 1998,  the Company  incurred a
one-time,  non-recurring charge of $2.7 million for costs assigned to in-process
research  and  development  activities  of the  acquired  company and  operating
expenses  for  severance  costs of $304,000  for  duplicative  employees  of the
Company as a result of the acquisition.  The aggregate  charges to income net of
taxes associated with the acquisition were approximately $1.9 million,  or $0.26
per share.

Six Months Ended June 30, 1998 Compared to Six Months Ended June 30, 1997

Total revenues. Total revenues increased 7.0% in the first six months of 1998 to
$7.4 million from $7.0  million in the first six months of 1997.  Revenues  from
the  Company's  renewable  performance  tracking  services  and custom  research
increased 7.0% to $7.0 million in the first six months of 1998 from $6.5 million
in the same period of 1997  primarily  due to the addition of new  clients,  the
acquisition  of HRS in June 1998,  and, to a lesser  extent,  an increase in the
scope of existing  tracking  projects.  Revenues  from the  Company's  renewable
syndicated  service  increased  6.0% to $471,000 in the first six months of 1998
from $444,000 in the same period of 1997. Such increase reflects the addition of
new syndicated service clients.

Direct  expenses.  Direct expenses  increased 17.1% to $3.5 million in the first
six  months of 1998  from $3.0  million  in the  first six  months of 1997.  The
increase in direct  expenses in the 1998 period was due to  increases in outside
field  services  of $64,000  and labor and  payroll  expenses  of  $500,000  due
partially to increased  costs  associated  with the addition of a telephone call
center and to increased  revenues.  Direct expenses increased as a percentage of
total  revenues  to 47.4% in the first six months of 1998 from 43.3%  during the
first six months of 1997.

Selling,   general   and   administrative   expenses.   Selling,   general   and
administrative expenses increased 32.3% to $2.4 million for the first six months
of 1998 from $1.8  million for the first six months of 1997.  This  increase was
primarily  due to an increase of $504,000  associated  with the expansion of the
Company's sales and marketing  workforce and an increase of $191,000  associated
with  being a public  company.  Selling,  general  and  administrative  expenses
increased as a percentage of total revenues to 32.7% for the first six months of
1998 from 26.4% for the first six months of 1997.

                                      -8-

<PAGE>

Depreciation and amortization.  Depreciation and amortization expenses increased
48.7% to $118,000 in the first six months of 1998 from  $80,000 in the first six
months  of  1997  partially  due to the  acquisition  of HRS.  Depreciation  and
amortization expenses increased as a percentage of total revenues to 1.6% in the
first six months of 1998 from 1.1% in the first six months of 1997.

Liquidity and Capital Resources

The Company's principal source of funds historically has been cash flow from its
operations.  The  Company's  cash flow has been  sufficient to provide funds for
working capital and capital expenditures.

As of June 30, 1998,  the Company had cash and cash  equivalents of $1.4 million
and working capital of $12.7 million.

During the six months ended June 30, 1998, the Company generated $2.5 million of
net cash from  operating  activities  as  compared  to $1.5  million of net cash
generated  during the same period in the prior year.  The  increase in cash flow
was  due  partially  to the  timing  of the  collection  of a  $717,000  account
receivable  in  January  1998 and the  timing of costs  incurred  in  advance of
billings on certain  projects,  combined  with  growth in  accounts  receivable,
unbilled revenues and billings in excess of cost.

For the six months  ended June 30, 1998,  net cash used in investing  activities
was $5.8  million as compared to net cash  provided of $938,000  during the same
period in the prior year.  The 1998  increase in cash used was  primarily due to
the acquisition of HRS in June 1998 for approximately $5.6 million, the accounts
receivable-other  related to the  acquisition  of  $649,000  and  investment  of
$714,000 in furniture,  computer equipment and production  equipment to meet the
expansion of the Company's business,  which was partially offset by the maturing
of investments in debt securities available-for-sale. The 1997 net cash provided
was primarily the maturing of investments available for sale which was partially
offset by an  investment  of  $232,000  in  furniture,  computer  equipment  and
production  equipment.  The  Company's  investments  available-for-sale  consist
principally of United States  government  securities  with  maturities of twelve
months or less.

Net cash used in  financing  activities  was $4,000 and $1.6 million for the six
months ended September 1998 and 1997,  respectively.  Net cash used in financing
activities  for 1998 was for the payments of notes  payable and for 1997 was the
result of S Corporation distributions to shareholders.

The  Company  typically  bills  clients  for  projects  before  they  have  been
completed.  Billed  amounts  are  recorded  as  billings  in  excess of costs or
deferred  revenue on the Company's  financial  statements  and are recognized as
income when earned. As of June 30, 1998 and as of December 31, 1997, the Company
had $3.9  million  and $2.3  million  of  deferred  revenues,  respectively.  In
addition, when work is performed in advance of billing, the Company records this
work as a cost in excess of billings or unbilled  revenue.  At June 30, 1998 and
December 31, 1997,  the Company had $914,000 and $560,000 of unbilled  revenues,
respectively.  Substantially  all deferred and unbilled  revenues will be earned
and billed, respectively, within 12 months of the respective period ends.

                                      -9-


<PAGE>


                           PART II - Other Information

ITEM 6   Exhibits and Reports on Form 8-K

  (a)      Exhibit Number           Description

           (27)                     Financial Data Schedule (EDGAR version only)

  (b)      Reports on Form 8-K

          On June 22,  1998,  the  Company  filed a Current  Report on Form 8-K,
dated  June 11,  1998,  to  reflect  (under  Item 2 of Form  8-K) the  Company's
acquisition  of HRS. On August 12, 1998,  the Company filed an amendment on Form
8-K/A to the  Company's  Current  Report on Form 8-K dated  June 11,  1998.  The
report, as amended,  included (under Item 7 of Form 8-K) the following financial
statements:  for HRS -- Balance  Sheets as of March 31,  1998 and  December  31,
1997,  Statements of Operations  and Statements of Cash Flows for the year ended
December  31,  1997 and the  three  months  ended  March  31,  1998 and 1997 and
Statements of Members'  Equity for the year ended December 31, 1997; and for the
Company -- Pro Forma Condensed  Consolidated  Balance Sheet as of March 31, 1998
and Pro Forma Condensed Consolidated Statements of Operations for the year ended
December 31, 1997 and for the three months ended March 31, 1998.

                                      -10-

<PAGE>


                                   SIGNATURES

Pursuant  to the  requirements  of the  Securities  Exchange  Act of  1934,  the
Registrant  has duly  caused  this  amendment  to be signed on its behalf by the
undersigned thereunto duly authorized.



                                   NATIONAL RESEARCH CORPORATION



Date: February 26, 1999            By:  /s/Patrick E. Beans
                                        Patrick E. Beans
                                        Vice President, Treasurer, Secretary
                                        and Chief Financial Officer

                                      -11-


<PAGE>



                          NATIONAL RESEARCH CORPORATION

                 EXHIBIT INDEX TO QUARTERLY REPORT ON FORM 10-Q
                  For the Quarterly Period ended June 30, 1998

                        Exhibit

(27)             Restated  Financial  Data Schedule  (EDGAR version only)


                                      -12-


<TABLE> <S> <C>


<ARTICLE>                     5
<LEGEND>
THE SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMAITON EXTRACTED FROM THE CONDENSED
FINANCIAL  STATEMENTS  OF NATIONAL  RESEARCH  CORPORATION  AS OF AND FOR THE SIX
MONTHS ENDED JUNE 30, 1998 AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH
FINANCIAL STATEMENTS.
</LEGEND>
<RESTATED>
<MULTIPLIER>                                      1,000
       
<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                           DEC-31-1998
<PERIOD-START>                              JAN-01-1998
<PERIOD-END>                                JUN-30-1998
<CASH>                                            1,424
<SECURITIES>                                     12,042
<RECEIVABLES>                                     3,990
<ALLOWANCES>                                         73
<INVENTORY>                                           0
<CURRENT-ASSETS>                                 19,922
<PP&E>                                            1,928
<DEPRECIATION>                                      656
<TOTAL-ASSETS>                                   25,451
<CURRENT-LIABILITIES>                             7,324
<BONDS>                                              90
                                 0
                                           0
<COMMON>                                              7
<OTHER-SE>                                       17,391
<TOTAL-LIABILITY-AND-EQUITY>                     25,451
<SALES>                                               0
<TOTAL-REVENUES>                                  7,436
<CGS>                                                 0
<TOTAL-COSTS>                                     3,525
<OTHER-EXPENSES>                                  5,591
<LOSS-PROVISION>                                      5
<INTEREST-EXPENSE>                                    1
<INCOME-PRETAX>                                  (1,680)
<INCOME-TAX>                                       (441)
<INCOME-CONTINUING>                              (1,680)
<DISCONTINUED>                                        0
<EXTRAORDINARY>                                       0
<CHANGES>                                             0
<NET-INCOME>                                       (723)
<EPS-PRIMARY>                                      (.10)
<EPS-DILUTED>                                      (.10)
        


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission